Health
Can Moderna shares rally on higher vaccine efficacy against Delta variant? – ig.com
Covid-19 vaccine maker Moderna’s stock has been on a tear this year, hitting record highs.
- Moderna (Nasdaq: MRNA) share price falls to US$456.76 per share
- The US biotech said it will not exceed its 2021 vaccine production target
- Modernas jab may be more effective against the Delta variant than its rivals shot, a study suggested
- Feeling bullish or…
Continue Reading
-
Noosa News22 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General15 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News16 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News23 hours agoFrank Moneger identified as man accused of hit-and-run death of 17-year-old girl in Margate, Queensland